GSK3B and cervical cancer: This finding is thus consistent with that of a previous study in cervical cancer cells, which demonstrated that DEK silencing inhibited tumorigenesis and metastasis by repressing p-Ser9-GSK-3β, leading to β-catenin degradation [21].